Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Regeneron Stock May Need More Than the Coronavirus

By Chris Markoch, InvestorPlace Contributor

The coronavirus is an immediate catalyst for Regeneron stock but it's also too unreliable to provide buyers with lasting confidence.

3 Dividend Stocks to Ride out the Market Volatility

By Chris Markoch, InvestorPlace Contributor

Dividend stocks are back as investors look for ways to ride out the volatility from the coronavirus outbreak. Here's three names to look at.

NOK Stock Has Few Options And Even Less Good Ones

By Chris Markoch, InvestorPlace Contributor

NOK stock is looking for a catalyst. However at every turn, the company is discovering that the solution may be worse than its problems.

Survey Says Beyond Meat Stock Lacks the Numbers to Find New Highs

By Chris Markoch, InvestorPlace Contributor

Beyond Meat stock is trading on the news, but the manufacturer of plant-based meat alternatives will need more than news to hit its numbers.

Buy Intel Stock Later, Not Now

By Chris Markoch, InvestorPlace Contributor

Intel stock is suffering the same fate as other chipmakers as the COVID-19 virus continues to introduce uncertainty to supply chains.

Canopy Growth Stock Reflects the Paradox of Cannabis Investing

By Chris Markoch, InvestorPlace Contributor

Any momentum CGC stock is gaining in Canada is being offset by supply concerns and a U.S. market that remains closed.

Software-maker Splunk Stock Looks Splendid Ahead of Earnings

By Chris Markoch, InvestorPlace Contributor

The more Splunk stock falls during this market selloff, the more opportunity investors have to grab the next leg up of its rally.

Inovio Stock Is Moving for the Wrong Reason

By Chris Markoch, InvestorPlace Contributor

Inovio stock has spiked sharply on hopes of a vaccine for the COVID-19 virus. But the real story of the stock lies in its pipeline.

3 of the Best Emerging Market Stocks to Buy Right Now

By Chris Markoch, InvestorPlace Contributor

Emerging market stocks may be an alternative for investors that are becoming anxious about the volatility in U.S. equities.

Ericsson Is Facing the Limitation of Hope

By Chris Markoch, InvestorPlace Contributor

ERIC stock has been trading in a narrow range despite the endorsement of analysts. The problems for the stock are showing the cost of 5G.

Load More